Although total levels of activated MMP-2 and MMP-9 may decrease in AMD donor eyes, an increase in high-molecular-weight proenzyme complexes likely hinders their activation, contributing to ECM thickening [87]. The gene discussed is MMP9; the disease is age-related macular degeneration.